Russia Prepares $10 COVID-19 Vaccine For International Launch

Aims To Compete With Pfizer On Efficacy, Undercut On Price

Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism.

Sputnik
Russia has just announced a second interim readout, edging its efficacy claims to over 95%. • Source: RDIF

More from Business

More from Scrip